PharmAthene, Inc.  

(Public, NYSEMKT:PIP)   Watch this stock  
Find more results for NYSEAMEX:PIP
1.30
+0.02 (1.56%)
Jul 31 - Close
NYSEMKT real-time data - Disclaimer
Currency in USD
Range 1.29 - 1.30
52 week 1.19 - 2.42
Open 1.29
Vol / Avg. 0.00/125,250.00
Mkt cap 70.56M
P/E     -
Div/yield     -
EPS -0.23
Shares 54.28M
Beta 1.42
Inst. own 37%
Sep 8, 2014
PharmAthene, Inc. at Rodman & Renshaw Global Investment Conference Add to calendar
Aug 7, 2014
Q2 2014 PharmAthene, Inc. Earnings Release- Tentative Add to calendar
Jun 11, 2014
PharmAthene, Inc. Annual Shareholder Meeting
May 8, 2014
Q1 2014 PharmAthene, Inc. Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '14) 2013
Net profit margin -60.35% -65.42%
Operating margin -64.18% -60.51%
EBITD margin - -59.49%
Return on average assets -57.49% -58.77%
Return on average equity -115.68% -123.29%
Employees 52 -
CDP Score - -

Address

Suite #450, One Park Place
ANNAPOLIS, MD 21401
United States - Map
+1-410-2692600 (Phone)
+1-410-2692601 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

PharmAthene, Inc. is a biodefense company engaged in the development and commercialization of medical countermeasures against biological and chemical threats. As of December 31, 2011, the Company�s biodefense portfolio of product candidates included SparVax, a second generation recombinant protective antigen (rPA) anthrax vaccine; Valortim, a fully human monoclonal antibody for the prevention and treatment of anthrax infection, and rBChE (recombinant butyrylcholinesterase) bioscavanger, a medical countermeasure for nerve agent poisoning by organophosphorous compounds, including nerve gases and pesticides.

Officers and directors

Mitchel B. Sayare Ph.D. Independent Chairman of the Board
Age: 66
Bio & Compensation  - Reuters
Eric I. Richman President, Chief Executive Officer, Director
Age: 53
Bio & Compensation  - Reuters
Linda L. Chang Chief Financial Officer, Senior Vice President
Age: 48
Bio & Compensation  - Reuters
Francesca M. Cook Senior Vice President - Policy and Government Affairs
Age: 49
Bio & Compensation  - Reuters
Wayne Morges Ph.D. Senior Vice President - Regulatory Affairs and Quality
Age: 67
Bio & Compensation  - Reuters
Arthur Y. Elliott Ph.D. Acting Chief Scientific Officer
Age: 78
Bio & Compensation  - Reuters
John M. Gill Independent Director
Age: 62
Bio & Compensation  - Reuters
Brian A. Markison Independent Director
Age: 54
Bio & Compensation  - Reuters
Joel W. McCleary Independent Director
Age: 65
Bio & Compensation  - Reuters
Jeffrey W. Runge M.D. Independent Director
Age: 58
Bio & Compensation  - Reuters